Preoperative Chemoradiotherapy for Resectable Gastric Cancer

In a trial comparing chemotherapy and preoperative chemoradiotherapy with perioperative chemotherapy in patients with resectable gastric or GE junction cancer, no significant difference in overall survival was noted.

​   The New England Journal of Medicine: Search Results in Gastroenterology